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Introduction rd generation cephalosporins are group of wide range of activity against most gram psitive & gram negative bacteria (1) . Cefotaxime is a 3rd generation Cephalosporin with a bactericidal action, it is highly stable by most β-lactamases & has greater activity than 1st & 2nd generation Cephalosporins against gbacteria & slightly less activity than 1st generation against g+ bacteria (2) . It is active invitro against many enterobacteria including Escherichia.coli, Klebsiella, Proteus, Providencia, Salmonella, Serratia,Shigella & Yersinea species. Other g-ve bacteria like penicillin resistant strains, H. influenze, N. gonorhea, N.meningetidis, Brucella melitensis, are reported to be moderately susceptible to it, but most are resistant (2, 3) . The active metabolite is active against many of the G -ve bacteria but not Pseudomonas (5) . (4) .
Ceftazidime has the same bactericidal action & broader spectrum of activity than cefotaxime but increased activity against Pseudomonas spp (2, 4, 5) . It is less active than staphylococci & streptococci (6) , it is active against some anaerobic bacteria although most strains of bacteroides fragilis & Clostridiadefficle are resistant. (2, 7) . Ceftriaxone activity is as for Cefotaxime but it has no active metabolite (9) .
Materials & Methods:
This is across-sectional study including one hundred specimens collected from 100 patients referred to a private medical laboratory by many physicians in Modified Kirby-bauer method was used for culture & sensitivity testing. Mueller-Hinton agar was prepared from dehydrated base the medium then cooled to 45-50C& poured into the plates, allowed to set on a level surface, to a depth of approximately 4mm. When the agar was solidified, the plates were dried for immediate use for 10-30 minutes at 37C by placing them in upright slightly tilted position in the incubator.
Small piece of the inoculums was taken from specific colony by sterile loop & dissolved in 5ml of normal saline in sterile tube under sterile conditions. The concentration of the suspension was measured by using spectrophotometer.
The plates then inoculated by dipping a sterile swab into the inoculum, the swab streaked all over the surface of medium 3 times, rotating the plate through an angle of 60 after each application, finally the swab passed round the edge of the agar surface, the inoculums then left to dry for few minutes at room temperature with the lid closed. The antibiotic discs were placed on the inoculated plates by using a sterile needle tip. The plates were placed in the incubator at 35 C within 30 minutes of the preparation. After overnight incubation the diameter of each zone measured & recorded in mm. The results then interpreted according to the critical diameters.
The drugs included in the study are Cefotaxime, Ceftazidime, & Ceftriaxone, which are commonly prescribed by many physicians & other health care personales even for asimple fever or cough. The patients are divided into 6 age groups < 1yr ,1-5 yrs , 6-10 yrs, 11-15 yrs ,16 -20 yrs & >20 yrs.
All data were analysed using the statistical package for social sciences (ssps program version 14), p≤0.05.
Results:
One hundred laboratory samples were collected from 100 patients & tested for culture & sensitivity to 3 rd generation Cephalosporins, the patients ages were ranging from <1yr to > 20 yrs, ( Table 2 shows that the urine & stool samples were the commenest 62(62%), 16(16%) respectively followed in order by throat swab 7(7%), semen & ear swab 4(4%), high vaginal swab 3(3%), csf & wound swabs each was 2(2%). 
Discussion
The mean age of patients according to the current study was 19 ± 8, this is slightly lower than that reported in another study done in Zarqaa, Jordan (3), which was 21± 8, &also slightly lower than that found in a study done in Sharjah, UAE (8) & was 20 ± 8. There was no statistical intersex association in relation to the development of resistance to 3 rd generation cephalosporins.
In relation to the culture & susceptibility results this study showed that Esh. Coli developed 64.7% resistance to cefotaxime 68.6% resistance to ceftazidime & 50.9% resistance to Ceftriaxone, these results were compared with those found in astudy on gram-bacilli & antibiotic consumption in Zarqaa, Jordan (3) in which E.coli showed 31%, 23%, & 31% resistance respectively to the above antibiotics. Regarding Klebsiella isolates resistance was 66.6% to Cefotaxime ,75% resistance to ceftazidime & 58.3% resistance to Ceftriaxone in the current study compared to 10% ,15%, 10% respectively in the Jordanian article (3) . All of the pseudomonas isolates resisted Cefotaxime in this study (100%) ,62.5% resisted Ceftazidime & Ceftriaxone , compared to 95% resistance to Cefotaxime, 15% resistance to Ceftazidime & 38% resistance to Ceftriaxone in the Jordanian article (3) . The proteus isolates developed 83% resistance to Cefotaxime, 66.6% resistance to Ceftazidime & Ceftriaxone, compared to 100% susceptibility to the above drugs in Zarqaa study (3) .
Regarding staphylococci isolates, our study detected 50% resistance to Cefotaxime, 75% resistance to Ceftazidime & 25% resistance to ceftriaxone, while streptococci showed 52.6% to Cefotaxime , 57.9% resistance to Ceftazidime & 31.6% resistance to Ceftriaxone , compared to 0% resistance of the 2 bacteria in a study conducted in Sharjah ,UAE (8) . 
